Novartis Venture Funds
Novartis Ventures focuses primarily on the development of novel therapeutics and platforms. They balance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In their investments, they look for unmet need...Homepage: http://www.venturefund.novartis.com/
Cambridge
USA MA
Phone: +41 61 324 32 67
Novartis Venture Funds at CrunchBase
Dr. Markus Goebel Managing Director
Past
January, 2013
Novartis Venture Funds invested $12M in Aileron Therapeutic as a Series D round
October, 2012
Novartis Venture Funds invested $16M in Thesan Pharmaceuticals as a Series A round
March, 2012
Novartis Venture Funds invested $12.5M in ImaginAb as a Series A round
Novartis Venture Funds invested $2.6M in BioRelix as unattributed round
February, 2012
Novartis Venture Funds invested $43M in Celladon as unattributed round
March, 2011
Novartis Venture Funds invested $11M in Advanced Animal Diagnostics as a Series B round
Novartis Venture Funds invested $4M in Euthymics Bioscience as a Series A round
November, 2010
Novartis Venture Funds invested $6.3M in Covagen as a Series A round
June, 2010
Novartis Venture Funds invested $29M in Foldrx Pharmaceuticals as unattributed round
March, 2010
Novartis Venture Funds invested $13.2M in Immune Targeting Systems as a Series A round
December, 2009
Novartis Venture Funds invested $16M in Evolva as a Series B round
July, 2009
Novartis Venture Funds invested $51M in Intellikine as a Series B round
June, 2009
Novartis Venture Funds invested $8M in Alios BioPharma as a Series A round
Novartis Venture Funds invested $40M in Aileron Therapeutic as a Series D round
February, 2009
Novartis Venture Funds invested $24M in Alios BioPharma as a Series A round
December, 2008
Novartis Venture Funds invested $8.3M in Diagnoplex as a Series A round
Novartis Venture Funds invested $40M in Catalyst Biosciences as a Series C round
August, 2008
Novartis Venture Funds invested $45M in Proteostasis Therapeutics as a Series A round
April, 2008
Novartis Venture Funds invested $2.3M in Biofisica as unattributed round
Novartis Venture Funds invested $10.5M in Aileron Therapeutic as a Series B round
Novartis Venture Funds invested $28M in LigoCyte Pharmaceuticals as a Series B round
September, 2007
Novartis Venture Funds invested $36.7M in Cellerix as a Series B round
July, 2007
Novartis Venture Funds invested $17.6M in Neovacs as unattributed round
June, 2007
Novartis Venture Funds invested $25.8M in BioRelix as a Series A round
December, 2006
Novartis Venture Funds invested $7M in Aileron Therapeutic as a Series A round
November, 2006
Novartis Venture Funds invested $16M in Intradigm Corporation as a Series A round
January, 2006
Novartis Venture Funds invested $12M in EraGen Biosciences as a Series A round